z-logo
open-access-imgOpen Access
Duration of Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease After Implantation of Endovascular Stents
Author(s) -
А Б Сумароков,
L. I. Buryachkovskaya,
Nikita Lomakin,
Y. V. Dotsenko,
I. Uchitel,
Л. А. Тимофеева
Publication year - 2018
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2018.1.10081
Subject(s) - medicine , cardiology , thrombosis , stent , surgery
Optimal duration of dual antiplatelet therapy (DAPT) after stent implantation is uncertain. Some patients have an extended risk of thrombotic complications including that of very late stent thrombosis after cessation of recommended course of DAPT (6-12 months). On the other hand, there is a real risk of bleeding on DAPT. In this review, we present and discuss results of clinical trials of long-term DAPT and data of their meta-analyses. The review also contains consideration of some aspects of new AHA/ACC recommendations (2016) on duration of DAPT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here